CBD for Knee Osteoarthritis
Recruiting · NCT06414473 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Florida
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Osteoarthritis is a disease that affects millions of Americans and is the leading cause of persistent pain and physical disability in the older adult population. Many physically active Americans have reported pain-relieving effects of cannabidiol (CBD) that can reduce or eliminate use of nonsteroidal anti-inflammatory drugs (NSAIDs) for activity-related pain with minimal to no side effects. Long-term use of over-the-counter medications, including NSAIDs, can pose a significant health risk, and therefore clinical research on the safety and efficacy of CBD is needed.
Who can take part
Inclusion criteria
- established clinical diagnosis of knee osteoarthritis (KOA)
- moderate to severe knee pain (≥4/10) with physical activity in one or both knees
Exclusion criteria
- pregnant (urine pregnancy test) or lactating
- current cannabis (THC and/or CBD) use (urine drug screen)
- any prior or ongoing medical condition that, in the investigators' opinion, could adversely affect the safety of the subject
- any major surgery within 3 months prior to recruitment or planned orthopedic surgery for any time during this study which would interfere with the ability to report pain or quality of life outcome measures
- any exposure to another investigational drug within 3 months prior to screening
- BMI ≥ 45
- current use of any enzyme-modifying drugs, including strong inhibitors or strong inducers of cytochrome P (CYP) enzymes
- history of:
- suicidal ideation or self-harm behavior
- seizure disorder or traumatic brain injury,
- liver or kidney disease, and
- cardiovascular diseases
Where it is running
1 location listed across 1 US state.
- Sports Medicine Research Laboratory - Gainesville, Florida, United States